-+ 0.00%
-+ 0.00%
-+ 0.00%

Zentalis Pharmaceuticals Doses First Patient In Phase 3 ASPENOVA Clinical Trial

Benzinga·05/05/2026 12:10:44
Listen to the news
  • Global Phase 3, randomized, controlled trial comparing azenosertib to standard-of-care chemotherapy now enrolling
  • ASPENOVA designed as confirmatory study to support DENALI Phase 2 accelerated approval pathway, pending FDA feedback